Feasibility of cardiovascular magnetic resonance to detect oxygenation deficits in patients with multi-vessel coronary artery disease triggered by breathing maneuvers

Kady Fischer, Kyohei Yamaji, Silvia Luescher, Yasushi Ueki, Bernd Jung, Hendrik von Tengg-Kobligk, Stephan Windecker, Matthias G Friedrich, Balthasar Eberle, Dominik P Guensch, Kady Fischer, Kyohei Yamaji, Silvia Luescher, Yasushi Ueki, Bernd Jung, Hendrik von Tengg-Kobligk, Stephan Windecker, Matthias G Friedrich, Balthasar Eberle, Dominik P Guensch

Abstract

Background: Hyperventilation with a subsequent breath-hold has been successfully used as a non-pharmacological vasoactive stimulus to induce changes in myocardial oxygenation. The purpose of this pilot study was to assess if this maneuver is feasible in patients with multi-vessel coronary artery disease (CAD), and if it is effective at detecting coronary artery stenosis > 50% determined by quantitative coronary angiography (QCA).

Methods: Twenty-six patients with coronary artery stenosis (QCA > 50% diameter stenosis) underwent a contrast-free cardiovascular magnetic resonance (CMR) exam in the time interval between their primary coronary angiography and a subsequent percutaneous coronary intervention (PCI, n = 24) or coronary artery bypass (CABG, n = 2) revascularization procedure. The CMR exam involved standard function imaging, myocardial strain analysis, T2 mapping, native T1 mapping and oxygenation-sensitive CMR (OS-CMR) imaging. During OS-CMR, participants performed a paced hyperventilation for 60s followed by a breath-hold to induce a vasoactive stimulus. Ten healthy subjects underwent the CMR protocol as the control group.

Results: All CAD patients completed the breathing maneuvers with an average breath-hold duration of 48 ± 23 s following hyperventilation and without any complications or adverse effects. In comparison to healthy subjects, CAD patients had a significantly attenuated global myocardial oxygenation response to both hyperventilation (- 9.6 ± 6.8% vs. -3.1 ± 6.5%, p = 0.012) and apnea (11.3 ± 6.1% vs. 2.1 ± 4.4%, p < 0.001). The breath-hold maneuver unmasked regional oxygenation differences in territories subtended by a stenotic coronary artery in comparison to remote territory within the same patient (0.5 ± 3.8 vs. 3.8 ± 5.3%, p = 0.011).

Conclusion: Breathing maneuvers in conjunction with OS-CMR are clinically feasible in CAD patients. Furthermore, OS-CMR demonstrates myocardial oxygenation abnormalities in regional myocardium related to CAD without the use of pharmacologic vasodilators or contrast agents. A larger trial appears warranted for a better understanding of its diagnostic utility.

Trial registration: Clinical Trials Identifier: NCT02233634 , registered 8 September 2014.

Keywords: BOLD; Breathing maneuvers; Coronary artery disease; Hypercapnia; Hypocapnia; Oxygenation-sensitive cardiovascular magnetic resonance.

Conflict of interest statement

Ethics approval and consent to participate

The study was approved by the cantonal ethics board of Bern (Swissethics-ID: PB_2016–02124) and complies with the Declaration of Helsinki. All subjects had given their informed consent prior to enrolment into the study.

Consent for publication

Not applicable.

Competing interests

KF, MF and DG hold an international patent (Patent Number: 9615754) and a second pending patent (US Patent Application No. 15/483,712) for the use of breathing maneuvers for diagnostics purpose. MF is board member, advisor, and shareholder of Circle Cardiovascular Imaging Inc., the manufacturer of the software used for CMR image evaluation.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Study Protocol. Patients were recruited between staged coronary interventions or the initial diagnostic angiography and surgical revascularization therapy. After primary angiography, QCA of all vessels was performed and patients were recruited if there was at least one untreated vessel with a significant lesion (diameter stenosis; DS > 50%). For oxygen sensitive cardiovascular magnetic resonance (OS-CMR), a rest image was obtained during a short breath-hold. Participants then hyperventilated for 60s (30 breaths per minute, paced by a metronome), controlled through qualitative capnography with visual confirmation of sufficient respiratory excursions. This was immediately followed by a long breath-hold, which was imaged throughout its entire duration with repetitive OS measurements (grey boxes). Quality control of apnea also included monitoring for absence of exhaled carbon dioxide with capnography and breathing motion artifacts in the images
Fig. 2
Fig. 2
Myocardial oxygenation response throughout the breath-hold. Left panel, top row (a): In healthy subjects, myocardial oxygenation increases rapidly at the beginning of the breath-hold and is maintained throughout apnea, as shown in a healthy male as well as by the mean response of all healthy subjects (right panel, grey shaded graph). Left panel, middle row (b): OS images show a regional response (square) in a coronary artery disease (CAD) patient, whose myocardial oxygenation decreased in territory subtended to left anterior descending (LAD) stenosis (marked with a solid lined box) and in territory reperfused via a stented right coronary artery (RCA) (marked with dotted line), while the remote territory responded with an oxygenation increase (left circumflex (LCx); also note artifact rejection in a small infero-lateral region). Left panel, bottom row (c): This sequence represents a CAD patient (stented LAD, RCA stenosis) with global dysfunction in whom all territories revealed an oxygenation deficit (purple dots).
Fig. 3
Fig. 3
Tissue characterization and ventricular strain. Mean ± SD are shown for T1 mapping, T2 mapping and peak circumferential strain for the global responses of healthy controls (Hea) and the patient group (CAD), along with the individual regional responses of the CAD patients for territories currently affected by a stenosis (Sten) > 50%DS, remote (Rem) and recently reperfused (Rep) territories. Three patients did not have a primary PCI procedure prior to the CMR exam (white markers). *p < 0.05 between groups for global analysis. †p < 0.05 for regional analysis of Sten or Rep vs. Rem
Fig. 4
Fig. 4
Global and regional OS-CMR. Mean ± SD are shown for the global responses of healthy control subjects (Hea) and the CAD patient group (CAD). Individual data points demonstrate that during the breath-hold (BH), the majority of patients had a lower response in the post-stenotic (Sten) and reperfused (Rep) territories than remote (Rem). Three patients did not have a primary PCI procedure prior to the CMR exam (white markers). *p < 0.05 between groups for global analysis. †p < 0.05 for regional analysis of Sten or Rep vs. Rem
Fig. 5
Fig. 5
Different patterns of myocardial oxygenation response and ischemia/reperfusion injury. A pictogram of the angiography results is shown for the RCA, LCx and LAD and their major branches (left to right), and collateralizations (red dotted lines). For the CMR images, the normal range (mean + SD) of the healthy subjects is shown in the colour legends below, with strain and OS-CMR shown at end-systole, and T1 and T2 imaged in diastole. Patients a and b underwent primary PCI during the first visit and have reperfused vascular territories in addition to a stenosis. Patients c-e were scheduled for a later PCI or CABG, thus their index angiography was only diagnostic and there is no revascularized territory at the time of the CMR scan. Solid line boxes highlight the post-stenotic and dotted lines the reperfused territories. Detailed information for each case is provided in the Additional file 2
Fig. 6
Fig. 6
Myocardial oxygenation in truncated breath-holds. In this patient with a 51% RCA stenosis (solid line box) and reperfused LAD (dotted line marker), an extended breath-hold could not be performed. Yet, with the last image obtained only at 13 s, the RCA territory already shows an oxygen deficit in comparison to the increase of the remote territory

References

    1. Nichols M, Townsend N, Scarborough P, Rayner M. Cardiovascular disease in Europe 2014: epidemiological update. Eur Heart J. 2014;35:2950–2959. doi: 10.1093/eurheartj/ehu299.
    1. Reiter T, Ritter O, Prince MR, Nordbeck P, Wanner C, Nagel E, et al. Minimizing risk of nephrogenic systemic fibrosis in cardiovascular magnetic resonance. J Magn Reson Imaging. 2012;14:31.
    1. Wacker CM, Bock M, Hartlep AW, Beck G, van Kaick G, Ertl G, et al. Changes in myocardial oxygenation and perfusion under pharmacological stress with dipyridamole: assessment using T*2 and T1 measurements. Magn Reson Med. 1999;41:686–695. doi: 10.1002/(SICI)1522-2594(199904)41:4<686::AID-MRM6>;2-9.
    1. Friedrich MG, Karamitsos TD. Oxygenation-sensitive cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2013;15:43. doi: 10.1186/1532-429X-15-43.
    1. Ogawa S, Lee TM, Nayak AS, Glynn P. Oxygenation-sensitive contrast in magnetic resonance image of rodent brain at high magnetic fields. Magn Reson Med. 1990;14:68–78. doi: 10.1002/mrm.1910140108.
    1. Guensch DP, Fischer K, Flewitt JA, Friedrich MG. Impact of intermittent apnea on myocardial tissue oxygenation—a study using oxygenation-sensitive cardiovascular magnetic resonance. PLoS One. 2013;8:e53282. doi: 10.1371/journal.pone.0053282.
    1. Guensch DP, Fischer K, Flewitt JA. Yu J, Lukic R, Friedrich JA, et al. breathing manoeuvre-dependent changes in myocardial oxygenation in healthy humans. Eur Heart J Cardiovasc Imaging. 2014;15:409–414. doi: 10.1093/ehjci/jet171.
    1. Wacker CM, Hartlep AW, Pfleger S, Schad LR, Ertl G, Bauer WR. Susceptibility-sensitive magnetic resonance imaging detects human myocardium supplied by a stenotic coronary artery without a contrast agent. J Am Coll Cardiol. 2003;41:834–840. doi: 10.1016/S0735-1097(02)02931-5.
    1. Luu JM, Friedrich MG, Harker J, Dwyer N, Guensch D, Mikami Y, et al. Relationship of vasodilator-induced changes in myocardial oxygenation with the severity of coronary artery stenosis: a study using oxygenation-sensitive cardiovascular magnetic resonance. Eur Heart J Cardiovasc Imaging. 2014;15:1358–1367. doi: 10.1093/ehjci/jeu138.
    1. Manka R, Paetsch I, Schnackenburg B, Gebker R, Fleck E, Jahnke CBOLD. Cardiovascular magnetic resonance at 3.0 tesla in myocardial ischemia. J Cardiovasc Magn Reson. 2010;12:54. doi: 10.1186/1532-429X-12-54.
    1. Friedrich MG, Niendorf T, Schulz-Menger J, Gross CM, Dietz R. Blood oxygen level-dependent magnetic resonance imaging in patients with stress-induced angina. Circulation. 2003;108:2219–2223. doi: 10.1161/01.CIR.0000095271.08248.EA.
    1. Neill W, Hattenhauer M. Impairment of myocardial O2 supply due to hyperventilation. Circulation. 1975;52:854–858. doi: 10.1161/01.CIR.52.5.854.
    1. Kety SS, Schmidt CF. The effects of active and passive hyperventilation on cerebral blood flow, cerebral oxygen consumption, cardiac output, and blood pressure of normal young men. J Clin Invest. 1946;25:107–119. doi: 10.1172/JCI101680.
    1. Fischer K, Guensch DP, Friedrich MG. Response of myocardial oxygenation to breathing manoeuvres and adenosine infusion. Eur Heart J Cardiovasc Imaging. 2015;16:395–401. doi: 10.1093/ehjci/jeu202.
    1. Fischer K, Guensch DP, Shie N, Lebel J, Friedrich MG. Breathing maneuvers as a vasoactive stimulus for detecting inducible myocardial ischemia – an experimental cardiovascular magnetic resonance study. PLoS One. 2016;11:e0164524. doi: 10.1371/journal.pone.0164524.
    1. Parkes MJ. Breath-holding and its breakpoint. Exp Physiol. 2006;91:1–15. doi: 10.1113/expphysiol.2005.031625.
    1. Guensch DP, Nadeshalingam G, Fischer K, Stalder AF, Friedrich MG. The impact of hematocrit on oxygenation-sensitive cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2016;18:42. doi: 10.1186/s12968-016-0262-1.
    1. Lima RSL, Watson DD, Goode AR, Siadaty MS, Ragosta M, Beller GA, et al. Incremental value of combined perfusion and function over perfusion alone by gated SPECT myocardial perfusion imaging for detection of severe three-vessel coronary artery disease. J Am Coll Cardiol. 2003;42:64–70. doi: 10.1016/S0735-1097(03)00562-X.
    1. Hoef TP. Van de, Bax M, Meuwissen M, Damman P, Delewi R, winter RJ de, et al. impact of coronary microvascular function on long-term cardiac mortality in patients with acute ST-segment–elevation myocardial infarction. Circ Cardiovasc Interv. 2013;6:207–215. doi: 10.1161/CIRCINTERVENTIONS.112.000168.
    1. Seiler C, Fleisch M, Meier B. Direct intracoronary evidence of collateral steal in humans. Circulation. 1997;96:4261–4267. doi: 10.1161/01.CIR.96.12.4261.
    1. Hussain ST, Chiribiri A, Morton G, Bettencourt N, Schuster A, Paul M, et al. Perfusion cardiovascular magnetic resonance and fractional flow reserve in patients with angiographic multi-vessel coronary artery disease. J Cardiovasc Magn Reson. 2016;18:44. doi: 10.1186/s12968-016-0263-0.
    1. Reinstadler SJ, Stiermaier T, Liebetrau J, Fuernau G, Eitel C, de Waha S, et al. Prognostic significance of remote myocardium alterations assessed by quantitative noncontrast T1 mapping in ST-segment elevation myocardial infarction. JACC: cardiovascular imaging. 2017; 10.1016/jjcmg2017.03.015.
    1. Roubille F, Fischer K, Guensch DP, Tardif J-C, Friedrich MG. Impact of hyperventilation and apnea on myocardial oxygenation in patients with obstructive sleep apnea – an oxygenation-sensitive CMR study. J Cardiol. 2017;69:489–494. doi: 10.1016/j.jjcc.2016.03.011.
    1. Taylor AJ, Al-Saadi N, Abdel-Aty H, Schulz-Menger J, Messroghli DR, Gross M, et al. Elective percutaneous coronary intervention immediately impairs resting microvascular perfusion assessed by cardiac magnetic resonance imaging. Am Heart J. 2006;151:891.e1–891.e7. doi: 10.1016/j.ahj.2005.09.021.
    1. Carrick D, Haig C, Ahmed N, McEntegart M, Petrie MC, Eteiba H, et al. Myocardial hemorrhage after acute Reperfused ST-segment–elevation myocardial infarction. Circ Cardiovasc Imaging. 2016;9:e004148. doi: 10.1161/CIRCIMAGING.115.004148.
    1. Germain P, El Ghannudi S, Jeung M-Y, Ohlmann P, Epailly E, Roy C, et al. Native T1 mapping of the heart – a pictorial review. Clin Med Insights Cardiol. 2014;8(Suppl 4):1–11.
    1. McComb C, Carrick D, McClure JD, Woodward R, Radjenovic A, Foster JE, et al. Assessment of the relationships between myocardial contractility and infarct tissue revealed by serial magnetic resonance imaging in patients with acute myocardial infarction. Int J Cardiovasc Imaging. 2015;31:1201–1209. doi: 10.1007/s10554-015-0678-y.
    1. Kalra PR, García-Moll X, Zamorano J, Kalra PA, Fox KM, Ford I, et al. Impact of chronic kidney disease on use of evidence-based therapy in stable coronary artery disease: a prospective analysis of 22,272 patients. PLoS One. 2014;9:e102335. doi: 10.1371/journal.pone.0102335.
    1. Jahnke C, Gebker R, Manka R, Schnackenburg B, Fleck E, Paetsch I. Navigator-gated 3D blood oxygen level–dependent CMR at 3.0-T for detection of stress-induced myocardial ischemic reactions. J Am Coll Cardiol Img. 2010;3:375–384. doi: 10.1016/j.jcmg.2009.12.008.
    1. Tonino PAL, Fearon WF, De Bruyne B, Oldroyd KG, Leesar MA, Ver Lee PN, et al. Angiographic versus functional severity of coronary artery Stenoses in the FAME study: fractional flow reserve versus angiography in multivessel evaluation. J Am Coll Cardiol. 2010;55:2816–2821. doi: 10.1016/j.jacc.2009.11.096.

Source: PubMed

3
Tilaa